Ephedra Supplement Restriction Appropriate Under DSHEA? -Hatch to Henney
This article was originally published in The Tan Sheet
Executive Summary
FDA Commissioner-nominee Jane Henney, MD, is asked to provide her views on the agency's use of adverse events data on ephedra-containing dietary supplements as a primary basis for proposed restrictions on such products in an Oct. 1 letter from Sen. Orrin Hatch (R-Utah).
You may also be interested in...
Andro Bill Driven By National Media Coverage, Biden Says
Attention from ESPN and other national media has been a primary impetus behind growing support for legislation that would make androstenedione and other steroid precursors controlled substances
Andro Bill Driven By National Media Coverage, Biden Says
Attention from ESPN and other national media has been a primary impetus behind growing support for legislation that would make androstenedione and other steroid precursors controlled substances
Andro Bill Driven By National Media Coverage, Biden Says
Attention from ESPN and other national media has been a primary impetus behind growing support for legislation that would make androstenedione and other steroid precursors controlled substances